Skip to main content
. 2023 Sep 8;2023(9):CD014805. doi: 10.1002/14651858.CD014805.pub2
Study Reason for exclusion
ECOG‐ACRIN EA1131 Study population included only people with TNBC with residual disease.
Jiang 2019 Paper was translated and we were advised that this study was not an RCT.
NCT00004092 It was not possible to decipher whether the cohort included people with TNBC. HER2 status was not checked.
SICOG 9908 Data were not reported separately for people with TNBC. Study investigators were contacted but did not respond.
UMIN000030780 – jRCTs051180210 Study population included only people with TNBC with residual disease.

HER2: human epidermal receptor 2; RCT: randomised controlled trial; TNBC: triple‐negative breast cancer.